Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications. - Wikidata - awgldk - TriplyDB

Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

http://www.wikidata.org/entity/Q38000562

about

Increased Long-Term Mortality among Black CABG Patients Receiving Preoperative Inotropic Agents Involvement of H1 and H2 receptors and soluble guanylate cyclase in histamine-induced relaxation of rat mesenteric collecting lymphatics.Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Cyclic nucleotide signalling in kidney fibrosis.Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.Effects of dynamic shear and transmural pressure on wall shear stress sensitivity in collecting lymphatic vessels.Effects of somatothermal far-infrared ray on primary dysmenorrhea: a pilot study.L-arginine-NO-cGMP signalling pathway in pancreatitis.Allosteric regulation of nucleotidyl cyclases: an emerging pharmacological target.ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains

P2860

Q30279050-78B1C9B1-1D57-4214-820E-300898D4529D Q30588880-CE48D195-4DE4-49B9-BE77-4A98B71DB4B4 Q35075847-E0037B05-EA97-4676-836A-68199CF5B0DF Q35138860-F77DA9D5-1237-4F32-8C4B-F6031882B2F2 Q35859307-954C7300-C24B-4806-872E-68AF0035B134 Q36339360-DDB865AD-94F1-4728-B94A-B35BE65B3877 Q36506673-3637C8E1-99C9-4E4E-856D-45399EFF7154 Q36878845-5D55DD0C-AF78-4276-A61A-DD92A4081C82 Q38040779-B78EA754-3685-4972-91D0-9F61438A5C6E Q38656360-A659F20B-A3AA-4B68-8D32-77F067E01F12 Q58696712-5B6BD00C-B524-40E4-9915-B8AA173C3BEB

P2860

Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications.

http://www.wikidata.org/entity/Q38000562

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Stimulators and activators of ...... ntial therapeutic indications.

@en

type

label

Stimulators and activators of ...... ntial therapeutic indications.

@en

prefLabel

Stimulators and activators of ...... ntial therapeutic indications.

@en

P1433

Q38000562-EC8F33C3-63F8-4B2C-9B93-89B024356BAB

P1476

Q38000562-3706C939-2636-48A4-9007-523055F2269B

P2093

Q38000562-A6BCD6CD-4491-4612-A358-D69C60E3FBBA

P2860

Q38000562-022FFABD-2E97-49F6-92CE-91C55594A395

Q38000562-06AAAE88-93CC-4E9B-88A2-8322A76794E4

Q38000562-070588DD-A7A0-4509-817E-DCEE1FE3A803

Q38000562-093F703C-DD4E-4A16-B7A5-1E988C4307E1

Q38000562-0D82A90C-F2C0-42FD-908F-B9F1B1C7DB62

Q38000562-0E973DD2-CBEE-4358-A4C3-597EAA59A854

Q38000562-1003F144-BE78-49C9-824A-ACF69AEB6D8D

Q38000562-139641B9-6009-4114-9D9B-CC0E2161BCDB

Q38000562-13EC0659-7568-487B-8DC4-655FD61C316C

Q38000562-166BA925-13A3-4955-A8CC-FFB2A607EAC1

P304

Q38000562-132D0BBF-09B3-42C6-A7B7-CF3CA8C8EE1C

P31

Q38000562-64DB1876-A552-431C-8CFF-F1E2F561627B

P356

Q38000562-2959F7BC-2EA9-494E-8713-D2650F66FE3C

P478

Q38000562-9D040F4D-5726-4C5F-9010-CD771B612091

P50

Q38000562-0027CFA6-E1F4-4AF9-B05C-0D223947FABF

Q38000562-D8DEC3B1-EC86-4E46-AF38-05BAC85D7631

P577

Q38000562-96768A78-11CE-4599-B6A3-77867B2D4138

P5875

Q38000562-579131F3-716A-431F-AE57-1E8E25AE6A56

P698

Q38000562-4761D29B-62FF-4802-92F1-792FA90C2455

P932

Q38000562-32307E01-C2C9-4FB5-83E2-F49AF7E09528

P356

P1433

Critical Care Research and Practice

P1476

Stimulators and activators of ...... ential therapeutic indications

@en

P2093

Philip Kadowitz

http://www.w3.org/2001/XMLSchema#string

P2860

An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

Heme-dependent and independent soluble guanylate cyclase activators and vasodilation.

GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico

Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme

Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine.

NO-independent regulatory site on soluble guanylate cyclase.

P304

290805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/290805

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Edward A Pankey

P577

2012-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223963471

http://www.w3.org/2001/XMLSchema#string

P698

22482042

http://www.w3.org/2001/XMLSchema#string

P932

3299283

http://www.w3.org/2001/XMLSchema#string